Not Medical Advice
The information on GLP1CompareHub.com is for educational and informational purposes only. It is not intended to replace professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition, treatment, or medication.
Always Consult Healthcare Professionals
GLP-1 medications (semaglutide, tirzepatide, and the branded versions Wegovy, Zepbound, Mounjaro, Ozempic, and Saxenda) are prescription drugs. They require evaluation by a licensed healthcare provider who can assess your full medical history, current medications, contraindications, and weight-loss goals. Do not start, stop, or modify any medication without consulting your prescriber.
Emergency Situations
If you are experiencing a medical emergency, call 911 immediately or go to the nearest emergency room. Do not rely on this website for urgent medical guidance.
GLP-1 Medication Warnings
- Prescription required. All GLP-1 medications require a valid prescription from a licensed prescriber.
- Side effects. Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain. Rare but serious side effects include pancreatitis, gallbladder disease, kidney injury, and thyroid C-cell tumors. See your prescriber for the full safety profile.
- Not for everyone. GLP-1 medications are contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- Pregnancy. GLP-1 medications are not recommended during pregnancy or breastfeeding. Notify your prescriber if you are pregnant, planning to become pregnant, or breastfeeding.
Pricing and Availability Disclaimer
Pricing and product availability shown on this site are based on data verified from each provider’s public website at the time of publication. Prices change frequently. Always verify current pricing directly with the provider before making a purchase decision. We do our best to update pricing monthly but cannot guarantee real-time accuracy.
No Provider Endorsement (Affiliate Disclosure)
GLP1CompareHub participates in affiliate programs with telehealth providers. We may earn a commission when you click our links and sign up — at no additional cost to you. Our editorial recommendations are not influenced by commission rates. We do not accept payment for placement in our rankings, and providers cannot purchase featured positions.
Compounded Medications Notice
Compounded GLP-1 medications (compounded semaglutide and compounded tirzepatide) are NOT FDA-approved drugs. They are produced by state-licensed 503A and 503B compounding pharmacies under specific FDA exemptions. While many patients use compounded GLP-1 successfully, the FDA has issued warnings about compounded versions. Consult your prescriber about whether a branded FDA-approved medication or a compounded alternative is right for your specific situation.
Individual Results Vary
Weight-loss outcomes from GLP-1 medications vary significantly between individuals based on diet, exercise, dose, individual response, comorbidities, and adherence. Clinical trial averages (e.g., 14.9% weight loss with semaglutide in STEP-1, 20.2% with tirzepatide in SURMOUNT-1) are population averages, not guarantees of personal outcome.
External Resources
Some pages on this site link to external sources including manufacturer websites, peer-reviewed clinical trials (NEJM, JAMA, Lancet), and government health resources (FDA, CDC, NIH). We are not responsible for the content, accuracy, or availability of external sites. Linking does not constitute endorsement.
Questions or Concerns
Email us through the contact page. We respond to medical-disclaimer and editorial-policy questions within one business day.
Last updated: May 2026